Endra Life Sciences Stock Today
| NDRA Stock | USD 5.25 0.25 5.00% |
Performance0 of 100
| Odds Of DistressOver 79
|
ENDRA Life is trading at 5.25 as of the 30th of January 2025, a 5.00 percent increase since the beginning of the trading day. The stock's open price was 5.0. ENDRA Life has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. The performance scores are derived for the period starting the 2nd of October 2024 and ending today, the 30th of January 2025. Click here to learn more.
ENDRA Life Sciences Inc. develops technology for improving the capabilities of clinical diagnostic ultrasound. ENDRA Life Sciences Inc. was incorporated in 2007 and is based in Ann Arbor, Michigan. Endra Life operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. The company has 536.91 K outstanding shares of which 39.39 K shares are now shorted by private and institutional investors with about 0.05 trading days to cover. More on ENDRA Life Sciences
Moving against ENDRA Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
ENDRA Stock Highlights
| Acting Chairman | Alexander Tokman |
| Thematic Idea | Medical Equipment (View all Themes) |
| Business Concentration | Health Care Equipment & Supplies, Health Care Equipment & Services, Health Care, NASDAQ Composite, NASDAQ Health Care, Medical Equipment, Health Care, Health Care Equipment & Supplies, Diagnostics & Research, Healthcare (View all Sectors) |
| Financial Strength | |
ENDRA Life Sciences (NDRA) is traded on NASDAQ Exchange in USA. It is located in 3600 Green Court, Ann Arbor, MI, United States, 48105-1570 and employs 21 people. ENDRA Life is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Nano-Cap' category with a current market capitalization of 2.68 M. ENDRA Life Sciences conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 536.91 K outstanding shares of which 39.39 K shares are now shorted by private and institutional investors with about 0.05 trading days to cover.
ENDRA Life Sciences currently holds about 11.28 M in cash with (9.55 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.18.
Check ENDRA Life Probability Of Bankruptcy
Ownership AllocationRoughly 99.23 percent of ENDRA Life outstanding shares are held by general public with 0.28 (percent) owned by insiders and only 0.49 % by other corporate entities.
Check ENDRA Ownership Details
ENDRA Life Sciences Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. ENDRA Life market risk premium is the additional return an investor will receive from holding ENDRA Life long position in a well-diversified portfolio.
| Risk Adjusted Performance | (0.06) | |||
| Jensen Alpha | (0.62) | |||
| Total Risk Alpha | (1.24) | |||
| Treynor Ratio | (27.64) |
ENDRA Stock Against Markets
ENDRA Life Corporate Management
| Michael Thornton | Chief Officer | Profile | |
| Renaud Maloberti | Chief Commercial Officer | Profile | |
| Ziad Rouag | Head Affairs | Profile | |
| Jonathan Behr | CoFounder | Profile | |
| Richard Jacroux | Chief Officer | Profile |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in ENDRA Life Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ENDRA Life. If investors know ENDRA will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ENDRA Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of ENDRA Life Sciences is measured differently than its book value, which is the value of ENDRA that is recorded on the company's balance sheet. Investors also form their own opinion of ENDRA Life's value that differs from its market value or its book value, called intrinsic value, which is ENDRA Life's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ENDRA Life's market value can be influenced by many factors that don't directly affect ENDRA Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ENDRA Life's value and its price as these two are different measures arrived at by different means. Investors typically determine if ENDRA Life is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ENDRA Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.